Janice Heard

Janice Heard serves as a Contracting Officer responsible for managing complex procurements within the federal acquisition system, with a focus on specialized scientific and healthcare-related goods and services. She plays a pivotal role in executing mission-critical acquisitions aligned with public health and laboratory technology needs, ensuring compliance with the Federal Acquisition Regulation and socioeconomic objectives. Her portfolio primarily encompasses analytical instrumentation, in-vitro diagnostics, and chemical product manufacturing, requiring deep technical understanding of laboratory-grade equipment and regulated chemical supply chains. Heard ensures acquisitions are competitively sourced, properly documented, and aligned with agency operational priorities, often navigating highly technical requirements to secure mission-ready solutions. While specific contractor names are not available, Heard consistently engages a diverse pool of vendors, including small businesses with specialized manufacturing capabilities and firms holding relevant quality certifications such as ISO 13485 and cGMP. Her procurement patterns reflect a preference for vendors with demonstrated expertise in regulated environments, particularly those capable of supporting FDA-aligned product development and validation protocols. She fosters collaborative relationships with suppliers who can meet stringent performance, safety, and traceability standards required for scientific and diagnostic applications. Heard demonstrates a strong commitment to small business participation, with over 68% of her awards designated as total small business set-asides under FAR 19.5. She actively prioritizes small business participation, with a notable emphasis on general small business concerns, while also incorporating a small but intentional percentage of Women-Owned Small Business contracts. Her approach reflects a deliberate strategy to broaden vendor diversity and promote equitable access to federal opportunities within technical manufacturing sectors. Her primary procurement focus lies in NAICS 334516 (Analytical Laboratory Instrument Manufacturing), 325413 (In-Vitro Diagnostic Substance Manufacturing), and 325998 (Miscellaneous Chemical Product Manufacturing), indicating deep expertise in scientific instrumentation, diagnostic reagents, and specialty chemical formulations. She regularly manages acquisitions for precision lab equipment, assay kits, and regulated chemical substances used in public health testing and research environments, requiring a nuanced understanding of technical specifications, regulatory compliance, and supply chain resilience.